Kim J S, Cho K-H, Kang D-W, Kwon S U, Suh D C
Stroke Center and Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, Korea.
Acta Neurol Scand. 2009 Aug;120(2):88-93. doi: 10.1111/j.1600-0404.2008.01124.x.
Although basilar artery atherosclerotic disease (BAD) is frequent in patients with pontine base infarction, it remains unknown whether BAD is related to the lesion size or clinical outcome.
We studied 56 patients with unilateral pontine base infarction who underwent (i) diffusion-weighted MRI within 48 h after stroke onset and (ii) follow-up MRI and MR angiography in the subacute stage. Neurologic progression was defined as increased National Institutes of Health Stroke Scale score by > or = 2 during admission. Clinical outcome was dichotomized as good and poor (> or = 3) according to the modified Rankin Scale at 1 month after stroke onset.
Twenty-two patients (39%) had BAD and 15 patients (27%) had neurologic progression. Follow-up MRI performed at median 3.5 +/- 1.1 days after the initial MRI showed the lesion volume significantly increased (P < 0.001). The BAD was not significantly related to demographic characteristics, risk factors, initial and follow-up lesion volume, neurologic progression and clinical outcome, but was closely related to the subacute increase in lesion volume (P = 0.004 for 20% increase, P = 0.029 for 50% increase).
BAD is related to subacute increase in lesion volume, but not to ultimate poor clinical outcome in patients with pontine base infarction.
尽管脑桥基底部梗死患者中基底动脉粥样硬化性疾病(BAD)很常见,但BAD是否与病变大小或临床结局相关仍不清楚。
我们研究了56例单侧脑桥基底部梗死患者,这些患者在卒中发作后48小时内接受了(i)扩散加权磁共振成像(MRI),并在亚急性期接受了(ii)随访MRI和磁共振血管造影。神经功能进展定义为入院期间美国国立卫生研究院卒中量表评分增加≥2分。根据卒中发作后1个月的改良Rankin量表,将临床结局分为良好和不良(≥3分)。
22例患者(39%)患有BAD,15例患者(27%)出现神经功能进展。在初次MRI后中位3.5±1.1天进行的随访MRI显示病变体积显著增加(P<0.001)。BAD与人口统计学特征、危险因素、初始和随访病变体积、神经功能进展及临床结局无显著相关性,但与病变体积的亚急性增加密切相关(增加20%时P=0.004,增加50%时P=0.029)。
BAD与脑桥基底部梗死患者病变体积的亚急性增加有关,但与最终不良临床结局无关。